% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • swhitemd50 swhitemd50 Dec 6, 2011 8:24 PM Flag


    Funny that the new data that prompted GILD to raise it's bid for Pharmasset was the study that showed PSI-7977/ribavirin cured every GT2/3 HCV patient. It made a great abbreviated headline which was picked up by various media organizations--that Pharmasset's new HCV drug cured 100 percent of patients. Problem is it was very misleading. The devil is in the details and the details are that most of the U.S. market consists of the harder to treat GT1 HCV patients and PSI-7977 cannot cure them without interferon injections and ribavirin. Every now and then, a big company like GILD makes an acquisition that's a colossal mistake. Remember Time Warner buying AOL? Of course, there are many other examples

80.63-1.53(-1.86%)May 4 4:00 PMEDT